Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.

Gabizon A, Amitay Y, Tzemach D, Gorin J, Shmeeda H, Zalipsky S.

J Control Release. 2012 Jun 10;160(2):245-53. doi: 10.1016/j.jconrel.2011.11.019. Epub 2011 Nov 26.

PMID:
22134116
2.

Heterobifunctional PEGs: efficient synthetic strategies and useful conjugation methodologies.

Levy DE, Frederick B, Luo B, Zalipsky S.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6823-6. doi: 10.1016/j.bmcl.2010.08.107. Epub 2010 Aug 25.

PMID:
20851602
3.

PEGylated iminodiacetic acid zinc complex stabilizes cationic RNA-bearing nanoparticles.

Levy DE, Ding Z, Hu C, Zalipsky S.

Bioorg Med Chem Lett. 2010 Sep 15;20(18):5499-501. doi: 10.1016/j.bmcl.2010.07.065. Epub 2010 Jul 21.

PMID:
20696578
4.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
5.

Thiolytically cleavable dithiobenzyl urethane-linked polymer-protein conjugates as macromolecular prodrugs: reversible PEGylation of proteins.

Zalipsky S, Mullah N, Engbers C, Hutchins MU, Kiwan R.

Bioconjug Chem. 2007 Nov-Dec;18(6):1869-78. Epub 2007 Oct 13.

PMID:
17935288
6.

Targeted binding of PLA microparticles with lipid-PEG-tethered ligands.

Duncanson WJ, Figa MA, Hallock K, Zalipsky S, Hamilton JA, Wong JY.

Biomaterials. 2007 Nov;28(33):4991-9. Epub 2007 Aug 17.

7.

Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action.

Zalipsky S, Saad M, Kiwan R, Ber E, Yu N, Minko T.

J Drug Target. 2007 Aug-Sep;15(7-8):518-30.

PMID:
17671898
8.

Pros and cons of the liposome platform in cancer drug targeting.

Gabizon AA, Shmeeda H, Zalipsky S.

J Liposome Res. 2006;16(3):175-83. Review.

PMID:
16952872
9.

Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.

Gabizon AA, Tzemach D, Horowitz AT, Shmeeda H, Yeh J, Zalipsky S.

Clin Cancer Res. 2006 Mar 15;12(6):1913-20.

10.

Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers.

Garbuzenko O, Zalipsky S, Qazen M, Barenholz Y.

Langmuir. 2005 Mar 15;21(6):2560-8.

PMID:
15752053
11.

Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremities of polymer chains.

Zalipsky S, Mullah N, Qazen M.

Methods Enzymol. 2004;387:50-69. No abstract available.

PMID:
15172157
12.

Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1177-92. Review.

PMID:
15094214
13.

In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.

Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S.

Clin Cancer Res. 2003 Dec 15;9(17):6551-9.

14.
15.

Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison.

Koning GA, Morselt HW, Gorter A, Allen TM, Zalipsky S, Scherphof GL, Kamps JA.

Pharm Res. 2003 Aug;20(8):1249-57.

PMID:
12948023
16.

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells.

Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM.

Biochim Biophys Acta. 2001 Dec 1;1515(2):144-58.

17.

Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.

Koning GA, Morselt HW, Gorter A, Allen TM, Zalipsky S, Kamps JA, Scherphof GL.

Pharm Res. 2001 Sep;18(9):1291-8.

PMID:
11683242
18.

Impact of polymer tether length on multiple ligand-receptor bond formation.

Jeppesen C, Wong JY, Kuhl TL, Israelachvili JN, Mullah N, Zalipsky S, Marques CM.

Science. 2001 Jul 20;293(5529):465-8.

19.

Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.

Clin Cancer Res. 2000 May;6(5):1949-57.

20.

Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.

Laverman P, Zalipsky S, Oyen WJ, Dams ET, Storm G, Mullah N, Corstens FH, Boerman OC.

J Nucl Med. 2000 May;41(5):912-8.

21.

New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine.

Zalipsky S, Qazen M, Walker JA 2nd, Mullah N, Quinn YP, Huang SK.

Bioconjug Chem. 1999 Sep-Oct;10(5):703-7.

PMID:
10502334
22.

Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.

Koning GA, Morselt HW, Velinova MJ, Donga J, Gorter A, Allen TM, Zalipsky S, Kamps JA, Scherphof GL.

Biochim Biophys Acta. 1999 Aug 20;1420(1-2):153-67.

23.

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.

Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen MM, Zalipsky S.

Bioconjug Chem. 1999 Mar-Apr;10(2):289-98.

PMID:
10077479
24.

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

Harding JA, Engbers CM, Newman MS, Goldstein NI, Zalipsky S.

Biochim Biophys Acta. 1997 Jul 25;1327(2):181-92.

25.

Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.

Zalipsky S, Mullah N, Harding JA, Gittelman J, Guo L, DeFrees SA.

Bioconjug Chem. 1997 Mar-Apr;8(2):111-8.

PMID:
9095350
26.

Direct measurement of a tethered ligand-receptor interaction potential.

Wong JY, Kuhl TL, Israelachvili JN, Mullah N, Zalipsky S.

Science. 1997 Feb 7;275(5301):820-2.

27.

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D.

Biochemistry. 1997 Jan 7;36(1):66-75.

PMID:
8993319
28.

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.

Goren D, Horowitz AT, Zalipsky S, Woodle MC, Yarden Y, Gabizon A.

Br J Cancer. 1996 Dec;74(11):1749-56.

30.

Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes.

Zalipsky S, Hansen CB, Oaks JM, Allen TM.

J Pharm Sci. 1996 Feb;85(2):133-7.

PMID:
8683436
31.

Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.

Murohara T, Margiotta J, Phillips LM, Paulson JC, DeFrees S, Zalipsky S, Guo LS, Lefer AM.

Cardiovasc Res. 1995 Dec;30(6):965-74.

PMID:
8746213
32.

Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR.

Zalipsky S, Puntambekar B, Boulikas P, Engbers CM, Woodle MC.

Bioconjug Chem. 1995 Nov-Dec;6(6):705-8.

PMID:
8608184
33.

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.

Hansen CB, Kao GY, Moase EH, Zalipsky S, Allen TM.

Biochim Biophys Acta. 1995 Nov 1;1239(2):133-44.

34.

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells.

Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S.

Biochim Biophys Acta. 1995 Jul 26;1237(2):99-108. Erratum in: Biochim Biophys Acta 1995 Dec 13;1240(2):285.

35.

Poly(methacrylic acid)-induced liposome aggregation for measuring drug entrapment.

Oto EK, Zalipsky S, Quinn YP, Zhu GZ, Uster PS.

Anal Biochem. 1995 Jul 20;229(1):106-11.

PMID:
8533878
36.

Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates.

Zalipsky S.

Bioconjug Chem. 1995 Mar-Apr;6(2):150-65. Review. No abstract available.

PMID:
7599259
37.

New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes.

Woodle MC, Engbers CM, Zalipsky S.

Bioconjug Chem. 1994 Nov-Dec;5(6):493-6.

PMID:
7873652
38.

Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine.

Zalipsky S, Brandeis E, Newman MS, Woodle MC.

FEBS Lett. 1994 Oct 10;353(1):71-4.

40.

Enzymatic activity of chymotrypsin and its poly(ethylene glycol) conjugates toward low and high molecular weight substrates.

Chiu HC, Zalipsky S, Kopecková P, Kopecek J.

Bioconjug Chem. 1993 Jul-Aug;4(4):290-5. Erratum in: Bioconjug Chem 1993 Sep-Oct;4(5):410.

PMID:
8110229
41.

Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers.

Nathan A, Zalipsky S, Ertel SI, Agathos SN, Yarmush ML, Kohn J.

Bioconjug Chem. 1993 Jan-Feb;4(1):54-62. Erratum in: Bioconjug Chem 1993 Sep-Oct;4(5):410.

PMID:
8431513
42.

Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins.

Zalipsky S, Seltzer R, Menon-Rudolph S.

Biotechnol Appl Biochem. 1992 Feb;15(1):100-14.

PMID:
1550659

Supplemental Content

Loading ...
Support Center